CTLA4 and Peripheral demyelination: In a model of EAE with anti-CTLA4 monoclonal antibody treated mice, disease severity was also exacerbated, indicating that CTLA4 pathway also plays a role attenuating T-cell activation in immune-mediated CNS demyelination (50).